Statin Use Impairs Cognition and is Associated with Voxel-wise and Network Based Grey Matter Atrophy: Findings from a Cohort Study

No abstract is available for this paper.

• Publication year

  2025

• Venue

  medRxiv

• Publication date

  2025-05-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1101/2025.05.09.25327347
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Statin use and dementia risk: A systematic review and updated meta‐analysis

  2025influential reference
• Low-density lipoprotein cholesterol levels and risk of incident dementia: a distributed network analysis using common data models

  2025cited by this paper
• Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission.

  2024cited by this paper
• Statin use is associated with higher white matter hyperintensity volumes and lower grey matter volumes

  2024cited by this paper
• Biomarkers and Cognition Study, Singapore (BIOCIS): Protocol, Study Design, and Preliminary Findings

  2024influential reference
• The Effects of Statins on Cognitive Performance Are Mediated by Low-Density Lipoprotein, C-Reactive Protein, and Blood Glucose Concentrations

  2023cited by this paper
• A systematic review and meta-analysis of the prevalence of dyslipidaemia among adults in Malaysia

  2023cited by this paper
• Global, regional and national trends in statin utilisation in high-income and low/middle-income countries, 2015–2020

  2022influential reference
• Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

  2022cited by this paper
• Abstract WP181: Statin Usage Increases White Matter Hyperintensities: A Post-hoc Analysis Of SPRINT-MIND

  2022cited by this paper
• Worldwide prevalence of mild cognitive impairment among community dwellers aged 50 years and older: a meta-analysis and systematic review of epidemiology studies.

  2022cited by this paper
• Statins and cognition: Modifying factors and possible underlying mechanisms

  2022cited by this paper
• Effects of simvastatin on white matter integrity in healthy middle‐aged adults

  2021cited by this paper
• Blood cholesterol and risk of dementia in more than 1·8 million people over two decades: a retrospective cohort study.

  2021cited by this paper
• Dementia in Southeast Asia: influence of onset-type, education, and cerebrovascular disease

  2021cited by this paper
• Color Trails Test: A New Set of Data on Cognitive Flexibility and Processing Speed in Schizophrenia

  2020cited by this paper
• The effects of statins on microglial cells to protect against neurodegenerative disorders: A mechanistic review

  2019cited by this paper
• Evidence and mechanisms for statin-induced cognitive decline

  2019cited by this paper
• Use of statins and the risk of dementia and mild cognitive impairment: A systematic review and meta-analysis

  2018cited by this paper
• Statins and Brain Health: Alzheimer’s and Cerebrovascular Disease Biomarkers in Older Adults

  2018cited by this paper
• Effects of sartans and low-dose statins on cerebral white matter hyperintensities and cognitive function in older patients with hypertension: a randomized, double-blind and placebo-controlled clinical trial

  2018cited by this paper
• Reversion From Mild Cognitive Impairment to Normal Cognition: A Meta-Analysis

  2016cited by this paper
• Early detection of dementia in multilingual populations: Visual Cognitive Assessment Test (VCAT)

  2015cited by this paper
• A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial.

  2015cited by this paper
• Statins and brain integrity in older adults: Secondary analysis of the Health ABC study

  2015cited by this paper
• Wechsler Adult Intelligence Scale–Fourth Edition

  2014cited by this paper
• Statin intolerance.

  2014influential reference
• Effectiveness of Montreal Cognitive Assessment for the diagnosis of mild cognitive impairment and mild Alzheimer's disease in Singapore.

  2013cited by this paper
• Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

  2011cited by this paper
• Statins and Cognitive Functioning in the Elderly: A Population-Based Study

  2010cited by this paper
• Neurodegenerative diseases target large-scale human brain networks.

  2009cited by this paper
• Mild cognitive impairment

  2006cited by this paper
• The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment

  2005cited by this paper
• Mild cognitive impairment as a diagnostic entity

  2004cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

  2002cited by this paper
• Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain

  2002cited by this paper
• Mild Cognitive Impairment Clinical Characterization and Outcome

  1999cited by this paper
• MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.

  1987cited by this paper
• A New Clinical Scale for the Staging of Dementia

  1982cited by this paper
• L’examen Clinique en Psychologie

  1959cited by this paper
• L'examen psychologique dans les cas d'encéphalopathie traumatique. (Les problems.).

  1941cited by this paper

• No citing papers are available for this paper.